BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#36 of 347

Andrew Fein

HC Wainwright & Co. · Equity Research Analyst
EstablishedRating since 2021No new ratings since May 2025

Analyst rating accuracy & track record

Andrew Fein is an equity research analyst at HC Wainwright & Co.. Bullish Whales has scored 152 of their stock calls across 28 companies. Their picks beat their sector 46% of the time over the next 12 months, and their price targets were reached 15% of the time within a year.

Win % vs sector
46%
PT Hit % (12mo)
15%
Avg sector-excess
+4.2%
Scored calls
152
Tickers
28
Tier
Established

Track record

Bullish Whales has scored 152 of Andrew Fein's stock calls across 28 companies, dating back to 2021. Their rated stocks beat their own sector 46% of the time over the next 12 months. On a typical call, a Fein pick returned +4.2% more than its sector over the following year.

Of the scored calls, 152 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
LQDALiquidia Technologies Inc
Buy$35.00May 2025+297.5%Hit
PRTAProthena Corporation plc
Buy$14.00May 2025+102.9%Miss
STOKStoke Therapeutics Inc
Buy$35.00May 2025+212.4%Hit
ANNXAnnexon Inc
Buy$14.00May 2025+183.5%Miss
GPCRStructure Therapeutics Inc. American Depositary Shares
Buy$75.00May 2025+45.8%Hit
LQDALiquidia Technologies Inc
Buy$29.00May 2025+241.4%Hit
ALECAlector Inc
Buy$10.00May 2025+63.7%Miss
PRTAProthena Corporation plc
Buy$30.00May 2025+20.0%Miss
AMLXAmylyx Pharmaceuticals Inc
Buy$16.00May 2025+216.4%Hit
KROSKeros Therapeutics Inc
Buy$25.00May 2025−21.7%Miss
DNLIDenali Therapeutics Inc
Buy$32.00May 2025+26.8%Miss
BCRXBioCryst Pharmaceuticals Inc
Buy$30.00May 2025−21.7%Miss
DBVTDBV Technologies
Buy$16.00May 2025+97.5%Hit
ARVNArvinas Inc
Buy$24.00May 2025+34.6%Miss
ACIUAC Immune Ltd
Buy$12.00May 2025+66.6%Miss
GPCRStructure Therapeutics Inc. American Depositary Shares
Buy$80.00Apr 2025+89.6%Hit
ACIUAC Immune Ltd
Buy$16.00Apr 2025+52.6%Miss
KROSKeros Therapeutics Inc
Buy$40.00Apr 2025+12.2%Miss
ABOSAcumen Pharmaceuticals Inc
Buy$11.00Mar 2025+98.8%Miss
SVRASavara Inc
Buy$6.00Mar 2025+82.1%Hit
ZNTLZentalis Pharmaceuticals Llc
Buy$10.00Mar 2025+15.1%Miss
LQDALiquidia Technologies Inc
Buy$29.00Mar 2025+139.9%Hit
STOKStoke Therapeutics Inc
Buy$47.00Mar 2025+297.0%Miss
ZNTLZentalis Pharmaceuticals Llc
Buy$10.00Mar 2025+50.5%Miss
ACIUAC Immune Ltd
Buy$16.00Mar 2025+36.9%Miss
KALVKalvista Pharmaceuticals Inc
Buy$20.00Mar 2025+30.0%Miss
PRQRProQR Therapeutics BV
Buy$12.00Mar 2025−1.2%Miss
FHTXFoghorn Therapeutics Inc
Buy$13.00Mar 2025+18.2%Miss
KMDAKamada
Buy$11.00Mar 2025+18.9%Miss
TARAProtara Therapeutics Inc
Buy$23.00Mar 2025+42.7%Miss
AMLXAmylyx Pharmaceuticals Inc
Buy$12.00Mar 2025+285.7%Hit
CPRXCatalyst Pharmaceuticals Inc
Buy$35.00Feb 2025−0.9%Miss
DNLIDenali Therapeutics Inc
Buy$87.00Feb 2025+30.3%Miss
ALECAlector Inc
Buy$7.00Feb 2025+38.7%Miss
KROSKeros Therapeutics Inc
Buy$40.00Feb 2025+18.6%Miss
BCRXBioCryst Pharmaceuticals Inc
Buy$30.00Feb 2025−18.3%Miss
PRTAProthena Corporation plc
Buy$48.00Feb 2025−46.6%Miss
PRTAProthena Corporation plc
Buy$48.00Feb 2025−49.7%Miss
CRBPCorbus Pharmaceuticals Holding
Buy$75.00Feb 2025−14.6%Miss
STOKStoke Therapeutics Inc
Buy$47.00Feb 2025+223.5%Miss
CRBPCorbus Pharmaceuticals Holding
Buy$75.00Feb 2025−18.0%Miss
ZNTLZentalis Pharmaceuticals Llc
Buy$10.00Jan 2025+45.0%Miss
CPRXCatalyst Pharmaceuticals Inc
Buy$35.00Jan 2025−8.7%Miss
KMDAKamada
Buy$11.00Jan 2025+1.9%Miss
FHTXFoghorn Therapeutics Inc
Buy$13.00Dec 2024−19.5%Miss
ANNXAnnexon Inc
Buy$30.00Dec 2024−15.0%Miss
KROSKeros Therapeutics Inc
Buy$47.00Dec 2024−4.7%Miss
PRQRProQR Therapeutics BV
Buy$10.00Dec 2024−28.9%Miss
KALVKalvista Pharmaceuticals Inc
Buy$20.00Dec 2024+74.0%Miss
TARAProtara Therapeutics Inc
Buy$23.00Dec 2024−20.8%Miss
Go to

Andrew Fein: analyst track record FAQ

Is Andrew Fein a good stock analyst?

Yes, by track record. Andrew Fein ranks number 36 of 347 of the analysts Bullish Whales scores, with a BW Score of 63 out of 100. Past results do not guarantee future ones.

What is Andrew Fein's win rate?

Andrew Fein's win rate is 46%. Across 152 scored calls, their rated stocks beat their sector 46% of the time over the next 12 months. On a typical call they returned +4.2% more than the sector.

What stocks and sectors does Andrew Fein cover?

Andrew Fein covers 28 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Andrew Fein's price targets accurate?

Andrew Fein's price targets are reached within 12 months 15% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Andrew Fein's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Andrew Fein rank among Wall Street analysts?

Andrew Fein ranks number 36 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30